Your browser doesn't support javascript.
loading
A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19.
Miyazaki, Taiga; Hosogaya, Naoki; Fukushige, Yuri; Takemori, Sachiko; Morimoto, Shinpei; Yamamoto, Hiroshi; Hori, Makoto; Ozawa, Yoshihito; Shiko, Yuki; Inaba, Yosuke; Kurokawa, Tomoya; Hanaoka, Hideki; Iwanami, Shoya; Kim, Kwangsu; Iwami, Shingo; Watashi, Koichi; Miyazawa, Ken; Umeyama, Takashi; Yamagoe, Satoshi; Miyazaki, Yoshitsugu; Wakita, Takaji; Sumiyoshi, Makoto; Hirayama, Tatsuro; Izumikawa, Koichi; Yanagihara, Katsunori; Mukae, Hiroshi; Kawasuji, Hitoshi; Yamamoto, Yoshihiro; Tarumoto, Norihito; Ishii, Hiroshi; Ohno, Hideaki; Yatera, Kazuhiro; Kakeya, Hiroshi; Kichikawa, Yoshiko; Kato, Yasuyuki; Matsumoto, Tetsuya; Saito, Makoto; Yotsuyanagi, Hiroshi; Kohno, Shigeru.
Afiliação
  • Miyazaki T; Division of Respirology, Rheumatology, Infectious Diseases, and Neurology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Hosogaya N; Nagasaki University, Nagasaki, Japan.
  • Fukushige Y; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan.
  • Takemori S; Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
  • Morimoto S; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan.
  • Yamamoto H; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan.
  • Hori M; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan.
  • Ozawa Y; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan.
  • Shiko Y; Division of Clinical Research Center, Chiba University Hospital, Chiba, Japan.
  • Inaba Y; Division of Clinical Research Center, Chiba University Hospital, Chiba, Japan.
  • Kurokawa T; Division of Clinical Research Center, Chiba University Hospital, Chiba, Japan.
  • Hanaoka H; Division of Clinical Research Center, Chiba University Hospital, Chiba, Japan.
  • Iwanami S; Division of Clinical Research Center, Chiba University Hospital, Chiba, Japan.
  • Kim K; Division of Clinical Research Center, Chiba University Hospital, Chiba, Japan.
  • Iwami S; interdisciplinary Biology Laboratory (iBLab), Division of Biological Sciences, Graduate School of Science, Nagoya University, Aichi, Japan.
  • Watashi K; interdisciplinary Biology Laboratory (iBLab), Division of Biological Sciences, Graduate School of Science, Nagoya University, Aichi, Japan.
  • Miyazawa K; interdisciplinary Biology Laboratory (iBLab), Division of Biological Sciences, Graduate School of Science, Nagoya University, Aichi, Japan.
  • Umeyama T; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.
  • Yamagoe S; Department of Fungal Infection, National Institute of Infectious Diseases, Tokyo, Japan.
  • Miyazaki Y; Department of Fungal Infection, National Institute of Infectious Diseases, Tokyo, Japan.
  • Wakita T; Section of Infectious Resource Coordination, Department of Research Resource, Center of Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Sumiyoshi M; Department of Fungal Infection, National Institute of Infectious Diseases, Tokyo, Japan.
  • Hirayama T; National Institute of Infectious Diseases, Tokyo, Japan.
  • Izumikawa K; Division of Respirology, Rheumatology, Infectious Diseases, and Neurology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Yanagihara K; Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
  • Mukae H; Department of Pharmacotherapeutics, Nagasaki University Graduate School of Biomedical Science, Nagasaki, Japan.
  • Kawasuji H; Infection Control and Education Center, Nagasaki University Hospital, Nagasaki, Japan.
  • Yamamoto Y; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
  • Tarumoto N; Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
  • Ishii H; Department of Infectious Disease, Toyama University Hospital, Toyama, Japan.
  • Ohno H; Department of Infectious Disease, Toyama University Hospital, Toyama, Japan.
  • Yatera K; Department of Infectious Disease and Infection Control, Saitama Medical University Hospital, Saitama, Japan.
  • Kakeya H; Department of Respiratory Medicine, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
  • Kichikawa Y; Department of Infectious Disease and Infection Control, Saitama Medical Center, Saitama, Japan.
  • Kato Y; Department of Respiratory Medicine, Hospital of the University of Occupational and Environmental Health, Japan, Fukuoka, Japan.
  • Matsumoto T; Department of Infection Control Science, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Saito M; Division of Respiratory Medicine, Mishuku Hospital, Tokyo, Japan.
  • Yotsuyanagi H; Department of Infectious Diseases, International University of Health and Welfare Narita Hospital, Chiba, Japan.
  • Kohno S; Department of Infectious Diseases, International University of Health and Welfare Narita Hospital, Chiba, Japan.
Microbiol Spectr ; 11(3): e0431122, 2023 06 15.
Article em En | MEDLINE | ID: mdl-37140398
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Anti-HIV / COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Microbiol Spectr Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Anti-HIV / COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Microbiol Spectr Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos